Search for: "IN RE MEDICIS PHARMACEUTICAL"
Results 1 - 20
of 27
Sorted by Relevance
|
Sort by Date
5 Apr 2012, 7:42 am
Jonah Shacknai, chairman and chief executive of Medicis Pharmaceutical (MRX) got one of the latter kinds in 2011 — but it isn’t quite what it seems, which may be unsurprising given the company’s colorful approach to pay. [read post]
21 Jan 2016, 12:08 pm
Medicis Pharmaceutical Corp., No. [read post]
21 Jan 2016, 12:08 pm
Medicis Pharmaceutical Corp., No. [read post]
19 Mar 2013, 7:00 am
Medicis Pharmaceutical Corp., 432 F.3d 1368, 1375 (Fed. [read post]
31 Aug 2010, 10:01 pm
(Spicy IP) India: DIPP discussion paper on compulsory licensing in the Indian Pharmaceutical sector: An ‘acquired’ afterthought? [read post]
21 Jan 2016, 12:50 pm
Medicis Pharmaceutical Corp., No. [read post]
28 Oct 2010, 3:10 am
Last week, in denying a temporary restraining order in Medicis Pharmaceutical and Corp, and AlyZan Inc., v. [read post]
16 Jan 2009, 5:00 am
(IP finance) US: Medarex, Eurand and Alexion file actions against Director Dudas seeking revised patent term adjustment determinations (Patent Docs) US: Kubin panel questions motivation behind reversal in new Written Description Training Materials (Patent Docs) US: The obviousness of DNA - Federal Circuit heard oral argument for In re Kubin last week (Patent Docs) Products Antara (Fenofibrate) – US: Oscient and Ethypharm file patent infringement suit against Lupin over… [read post]
5 Dec 2008, 1:00 pm
(Holman's Biotech IP Blog) IP and genetically modified organisms: a fateful combination, activists say (Intellectual Property Watch) Australia: Gene patent delays diagnosis and treatment for babies with severe form of epilepsy: (Techdirt) Brazil: Brazilian draft law would curb expanded patents on pharmaceuticals (Intellectual Property Watch) (IP tango) EU: European Commission issues preliminary report on its inquiry into competition in the pharmaceutical sector (IPKat)… [read post]
31 May 2011, 8:38 pm
Novo Nordisk (Orange Book Blog) Silenor (Doxepin) – US: Somaxon files patent infringement lawsuit against Par Pharmaceuticals over bid to market generic Silenor (GenericsWeb) Strattera (Atomoxetine) – US: Eli Lilly files patent infringement complaint against Zydus in response to Para IV certification (Patent Docs) Zemplar (Paricalcitol) – US: Abbott Lab’s files patent infringement complaint against Sandoz in response to Para IV certification (Patent Docs) Ziana… [read post]
9 Dec 2009, 3:59 pm
Teva Pharmaceuticals USA Inc. [read post]
27 May 2010, 3:20 am
Anchen Pharmaceuticals Inc et al. [read post]
17 Jan 2008, 10:00 pm
breaks new ground: (Rouse & Co International), Stopping China online content theft: (China Law Blog),Taking depositions in China: (Part 1 - Experience Not Logic), (Part 2 - Experience Not Logic), (Part 3 - Experience Not Logic).IP re-education a Sisyphean task: (China Hearsay),Patent challenge in China: What's the state of the art? [read post]
27 Jul 2011, 1:01 am
KG (TTABlog) US: ALJ Rogers sets 17-month target date in Certain Coenzyme Q10 Products (337-TA-790) (ITC 337 Law Blog) Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement complaints against APP Pharmaceuticals in Delaware and S D Indiana in response to Para IV certification filing (Patent Docs) Cenestin (Synthetic conjugated estrogens) – US: CAFC: Prosecution history estoppel bars Duramed’s allegations of infringement under doctrine of… [read post]
5 Feb 2016, 7:53 am
Medicis Pharmaceutical Corp., No. cv-15-0065-PR, 2016 WL 237777 (Ariz. [read post]
3 Mar 2016, 5:19 am
Medicis Pharmaceutical Corp., ___ P.3d ___, 2016 WL 237777, at *5 (Ariz. [read post]
24 Dec 2015, 8:20 am
Medicis Pharmaceutical Corp., 342 P.3d 847 (Ariz. [read post]
12 Feb 2010, 11:02 am
Medicis Pharm. [read post]
18 Jul 2014, 11:55 am
Wyeth Pharmaceuticals, Inc., 2008 WL 7136137 (Ala. [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP) Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) Events 26 August:… [read post]
